应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02157 乐普生物-B
未开盘 11-18 16:08:08
3.010
-0.180
-5.64%
最高
3.220
最低
2.980
成交量
270.90万
今开
3.220
昨收
3.190
日振幅
7.52%
总市值
51.49亿
流通市值
49.85亿
总股本
17.11亿
成交额
828.79万
换手率
0.16%
流通股本
16.56亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
乐普生物-B盘中异动 快速下挫5.02%报3.030港元
市场透视 · 11-18 15:39
乐普生物-B盘中异动 快速下挫5.02%报3.030港元
乐普生物-B(02157)下跌5.02%,报3.03元/股
金融界 · 11-18 15:39
乐普生物-B(02157)下跌5.02%,报3.03元/股
乐普生物-B(02157)下跌5.07%,报3.37元/股
金融界 · 11-13
乐普生物-B(02157)下跌5.07%,报3.37元/股
乐普生物-B盘中异动 大幅下跌5.07%
市场透视 · 11-13
乐普生物-B盘中异动 大幅下跌5.07%
乐普生物-B11月12日主力资金流入52万元 连续3日加仓
市场透视 · 11-12
乐普生物-B11月12日主力资金流入52万元 连续3日加仓
乐普生物-B盘中异动 股价大涨5.23%报3.420港元
市场透视 · 11-11
乐普生物-B盘中异动 股价大涨5.23%报3.420港元
港股异动 | 部分医药股走高 医保谈判支持创新药 机构指板块仍有进一步修复空间
智通财经 · 11-08
港股异动 | 部分医药股走高 医保谈判支持创新药 机构指板块仍有进一步修复空间
乐普生物-B盘中异动 急速拉升5.25%
市场透视 · 11-08
乐普生物-B盘中异动 急速拉升5.25%
乐普生物-B11月06日遭主力抛售118万元 环比增加391.67%
市场透视 · 11-06
乐普生物-B11月06日遭主力抛售118万元 环比增加391.67%
乐普生物-B10月28日遭主力抛售73万元 环比增加151.72%
市场透视 · 10-28
乐普生物-B10月28日遭主力抛售73万元 环比增加151.72%
乐普生物-B(02157)上涨5.05%,报3.12元/股
金融界 · 10-25
乐普生物-B(02157)上涨5.05%,报3.12元/股
乐普生物-B盘中异动 股价大涨5.05%报3.120港元
市场透视 · 10-25
乐普生物-B盘中异动 股价大涨5.05%报3.120港元
乐普生物-B盘中异动 下午盘股价大涨5.03%报3.130港元
市场透视 · 10-18
乐普生物-B盘中异动 下午盘股价大涨5.03%报3.130港元
乐普生物-B(02157)上涨10.6%,报3.34元/股
金融界 · 10-17
乐普生物-B(02157)上涨10.6%,报3.34元/股
乐普生物-B盘中异动 快速上涨5.30%报3.180港元
市场透视 · 10-17
乐普生物-B盘中异动 快速上涨5.30%报3.180港元
乐普生物-B(02157)下跌5.0%,报3.23元/股
金融界 · 10-14
乐普生物-B(02157)下跌5.0%,报3.23元/股
乐普生物-B盘中异动 早盘快速跳水5.59%
市场透视 · 10-14
乐普生物-B盘中异动 早盘快速跳水5.59%
乐普生物-B10月10日遭主力抛售32万元 环比增加700.00%
市场透视 · 10-10
乐普生物-B10月10日遭主力抛售32万元 环比增加700.00%
乐普生物-B盘中异动 股价大跌5.47%
市场透视 · 10-09
乐普生物-B盘中异动 股价大跌5.47%
乐普生物-B(02157)股价上升9.653%,现价港币$4.43
阿斯达克财经 · 10-07
乐普生物-B(02157)股价上升9.653%,现价港币$4.43
加载更多
公司概况
公司名称:
乐普生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。该公司主要研发肿瘤候选药物的产品管线,包括处于临床及临床前阶段的ADC、溶瘤病毒药物及免疫疗法。该公司主要在研管线资产包括MRG003、MRG002、HX008及LP002,及三种关键临床阶段候选药物。该公司产品销往海内外市场。
发行价格:
--
{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"乐普生物-B","latestPrice":3.01,"timestamp":1731917288014,"preClose":3.19,"halted":0,"volume":2709000,"delay":0,"floatShares":1655999999,"shares":1710614838,"eps":-0.014336663,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.18,"latestTime":"11-18 16:08:08","open":3.22,"high":3.22,"low":2.98,"amount":8287930,"amplitude":0.075235,"askPrice":3.01,"askSize":11000,"bidPrice":2.99,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.04696912760872781,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1645545600000,"adjPreClose":3.19,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.452919146655747,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157","defaultTab":"news","newsList":[{"id":"2484617678","title":"乐普生物-B盘中异动 快速下挫5.02%报3.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484617678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484617678?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:39","pubTimestamp":1731915567,"startTime":"0","endTime":"0","summary":"2024年11月18日临近收盘15时39分,乐普生物-B股票出现异动,股价大幅下挫5.02%。截至发稿,该股报3.030港元/股,成交量186.6万股,换手率0.11%,振幅5.96%。资金方面,该股资金流入187.928万港元,流出267.291万港元。乐普生物-B股票所在的生物技术行业中,整体跌幅为1.36%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153927a2422f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153927a2422f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2484614017","title":"乐普生物-B(02157)下跌5.02%,报3.03元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484614017","media":"金融界","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484614017?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:39","pubTimestamp":1731915565,"startTime":"0","endTime":"0","summary":"11月18日,乐普生物-B(02157)盘中下跌5.02%,截至15:39,报3.03元/股,成交575.38万元。乐普生物科技股份有限公司主要市场在中国,专注于肿瘤治疗领域的生物制药研发,特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力,并已经建立了专业的销售和营销团队,旨在满足临床需求,提供优化和创新的药物解决方案。截至2024年中报,乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/18153945394748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2483613090","title":"乐普生物-B(02157)下跌5.07%,报3.37元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483613090","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483613090?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:50","pubTimestamp":1731462615,"startTime":"0","endTime":"0","summary":"11月13日,乐普生物-B(02157)盘中下跌5.07%,截至09:50,报3.37元/股,成交692.04万元。乐普生物科技股份有限公司主要市场在中国,专注于肿瘤治疗领域的生物制药研发,特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力,并已经建立了专业的销售和营销团队,旨在满足临床需求,提供优化和创新的药物解决方案。截至2024年中报,乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/13095045230362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2483901850","title":"乐普生物-B盘中异动 大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483901850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483901850?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:50","pubTimestamp":1731462610,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘09时50分,乐普生物-B股票出现异动,股价快速下跌5.07%。截至发稿,该股报3.370港元/股,成交量197.7万股,换手率0.12%,振幅6.20%。乐普生物-B股票所在的生物技术行业中,整体跌幅为1.30%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113095010abbb8cae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113095010abbb8cae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2482672423","title":"乐普生物-B11月12日主力资金流入52万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482672423","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482672423?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:15","pubTimestamp":1731399307,"startTime":"0","endTime":"0","summary":"11月12日, 乐普生物-B股价涨4.72%,报收3.55元,成交金额3149万元,换手率0.54%,振幅9.73%,量比1.83。乐普生物-B今日主力资金净流入52万元,连续3日净流入,上一交易日主力净流入133万元,今日环比减少60.90%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为50.00%,平均涨幅为2.79%。该股近5个交易日上涨16.67%,主力资金累计净流入157万元;近20日主力资金累计净流出40万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161513abb93187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161513abb93187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2482210484","title":"乐普生物-B盘中异动 股价大涨5.23%报3.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482210484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482210484?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:34","pubTimestamp":1731288866,"startTime":"0","endTime":"0","summary":"2024年11月11日早盘09时34分,乐普生物-B股票出现异动,股价大幅上涨5.23%。截至发稿,该股报3.420港元/股,成交量64.8万股,换手率0.04%,振幅3.69%。资金方面,该股资金流入116.809万港元,流出90.076万港元。乐普生物-B股票所在的生物技术行业中,整体跌幅为0.70%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。该公司产品销往海内外市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111109342898e41a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111109342898e41a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2481416046","title":"港股异动 | 部分医药股走高 医保谈判支持创新药 机构指板块仍有进一步修复空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2481416046","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481416046?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:48","pubTimestamp":1731034083,"startTime":"0","endTime":"0","summary":"消息面上,据国家医保局此前介绍,2024年国家医保药品目录调整现场谈判已顺利结束,“扩容”后的新版医保药品目录预计于11月底对外发布,2025年1月1日起正式实施。西南证券表示,创新药国谈和三季报落地。创新药国谈方向投资机会值得期待。交银国际表示,近期医药板块在大幅震荡后小幅回升,考虑到板块估值仍处于历史底部、叠加后续宏观利好政策出台+流动性改善,该行认为仍有进一步修复空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1515","02171","01952","BK1583","BK1161","06978","02157","BK1585","159992","09966","BK1587","09939","BK1574"],"gpt_icon":0},{"id":"2481816124","title":"乐普生物-B盘中异动 急速拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481816124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481816124?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:58","pubTimestamp":1731031088,"startTime":"0","endTime":"0","summary":"2024年11月08日早盘09时58分,乐普生物-B股票出现波动,股价快速拉升5.25%。截至发稿,该股报3.210港元/股,成交量124万股,换手率0.07%,振幅4.59%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.60%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。该公司产品销往海内外市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108095808971a53d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108095808971a53d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2481626827","title":"乐普生物-B11月06日遭主力抛售118万元 环比增加391.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481626827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481626827?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:16","pubTimestamp":1730880984,"startTime":"0","endTime":"0","summary":"11月06日, 乐普生物-B股价跌2.61%,报收2.98元,成交金额919万元,换手率0.18%,振幅6.54%,量比2.31。乐普生物-B今日主力资金净流出118万元,上一交易日主力净流出24万元,今日环比增加391.67%。该股近5个交易日下跌1.64%,主力资金累计净流出117万元;近20日主力资金累计净流出404万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161650a21bf438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161650a21bf438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2478398173","title":"乐普生物-B10月28日遭主力抛售73万元 环比增加151.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478398173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478398173?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:15","pubTimestamp":1730103354,"startTime":"0","endTime":"0","summary":"10月28日, 乐普生物-B股价涨0.32%,报收3.11元,成交金额527万元,换手率0.10%,振幅3.55%,量比0.83。乐普生物-B今日主力资金净流出73万元,连续3日净流出,上一交易日主力净流出29万元,今日环比增加151.72%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为4.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161619ab7abc6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028161619ab7abc6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2478640028","title":"乐普生物-B(02157)上涨5.05%,报3.12元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2478640028","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478640028?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:30","pubTimestamp":1729827000,"startTime":"0","endTime":"0","summary":"10月25日,乐普生物-B(02157)盘中上涨5.05%,截至11:30,报3.12元/股,成交326.07万元。乐普生物科技股份有限公司主要市场在中国,专注于肿瘤治疗领域的生物制药研发,特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力,并已经建立了专业的销售和营销团队,旨在满足临床需求,提供优化和创新的药物解决方案。截至2024年中报,乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/25113044453530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2478477756","title":"乐普生物-B盘中异动 股价大涨5.05%报3.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478477756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478477756?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:29","pubTimestamp":1729826994,"startTime":"0","endTime":"0","summary":"2024年10月25日早盘11时29分,乐普生物-B股票出现异动,股价急速上涨5.05%。截至发稿,该股报3.120港元/股,成交量106.1万股,换手率0.06%,振幅3.70%。资金方面,该股资金流入160.724万港元,流出112.46万港元。乐普生物-B股票所在的生物技术行业中,整体涨幅为1.35%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025112954971a23ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025112954971a23ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2476447455","title":"乐普生物-B盘中异动 下午盘股价大涨5.03%报3.130港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476447455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476447455?lang=zh_cn&edition=full","pubTime":"2024-10-18 13:15","pubTimestamp":1729228528,"startTime":"0","endTime":"0","summary":"2024年10月18日下午盘13时15分,乐普生物-B股票出现波动,股价急速拉升5.03%。截至发稿,该股报3.130港元/股,成交量138.6万股,换手率0.08%,振幅5.03%。资金方面,该股资金流入176.267万港元,流出102.682万港元。乐普生物-B股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,云顶新耀-B、来凯医药-B、药明合联涨幅较大,振幅较大的相关个股有方达控股、和誉-B、云顶新耀-B,振幅分别为22.00%、16.67%、13.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018131528a1e1988e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018131528a1e1988e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2476157316","title":"乐普生物-B(02157)上涨10.6%,报3.34元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476157316","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476157316?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:09","pubTimestamp":1729141743,"startTime":"0","endTime":"0","summary":"10月17日,乐普生物-B(02157)盘中上涨10.6%,截至13:09,报3.34元/股,成交420.18万元。乐普生物科技股份有限公司主要市场在中国,专注于肿瘤治疗领域的生物制药研发,特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力,并已经建立了专业的销售和营销团队,旨在满足临床需求,提供优化和创新的药物解决方案。截至2024年中报,乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/17130944096568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2476157438","title":"乐普生物-B盘中异动 快速上涨5.30%报3.180港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476157438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476157438?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:07","pubTimestamp":1729141646,"startTime":"0","endTime":"0","summary":"2024年10月17日下午盘13时07分,乐普生物-B股票出现波动,股价大幅拉升5.30%。截至发稿,该股报3.180港元/股,成交量82.8万股,换手率0.05%,振幅5.63%。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.44%。其相关个股中,来凯医药-B、三叶草生物-B、奥星生命科技涨幅较大,振幅较大的相关个股有来凯医药-B、三叶草生物-B、方达控股,振幅分别为24.31%、20.00%、10.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101713072698e3ceea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101713072698e3ceea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2475030368","title":"乐普生物-B(02157)下跌5.0%,报3.23元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475030368","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475030368?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:34","pubTimestamp":1728869678,"startTime":"0","endTime":"0","summary":"10月14日,乐普生物-B(02157)盘中下跌5.0%,截至09:34,报3.23元/股,成交119.61万元。乐普生物科技股份有限公司主要市场在中国,专注于肿瘤治疗领域的生物制药研发,特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力,并已经建立了专业的销售和营销团队,旨在满足临床需求,提供优化和创新的药物解决方案。截至2024年中报,乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/14093443957562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2475805620","title":"乐普生物-B盘中异动 早盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475805620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475805620?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:32","pubTimestamp":1728869562,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘09时32分,乐普生物-B股票出现波动,股价快速下跌5.59%。截至发稿,该股报3.210港元/股,成交量14.7万股,换手率0.01%,振幅5.88%。乐普生物-B股票所在的生物技术行业中,整体跌幅为1.11%。其相关个股中,绿竹生物-B、晶泰科技、北海康成-B涨幅较大,振幅较大的相关个股有科济药业-B、药明巨诺-B、来凯医药-B,振幅分别为8.42%、7.77%、6.09%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410140932429719fe7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410140932429719fe7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2474793269","title":"乐普生物-B10月10日遭主力抛售32万元 环比增加700.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474793269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474793269?lang=zh_cn&edition=full","pubTime":"2024-10-10 16:15","pubTimestamp":1728548154,"startTime":"0","endTime":"0","summary":"10月10日, 乐普生物-B股价跌5.03%,报收3.40元,成交金额1393万元,换手率0.24%,振幅14.53%,量比0.92。乐普生物-B今日主力资金净流出32万元,连续3日净流出,上一交易日主力净流出4万元,今日环比增加700.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为40.00%,平均跌幅为2.91%。该股近5个交易日下跌10.99%,主力资金累计净流出335万元;近20日主力资金累计净流入416万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010161631959cdd2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010161631959cdd2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2474725354","title":"乐普生物-B盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474725354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474725354?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:40","pubTimestamp":1728438014,"startTime":"0","endTime":"0","summary":"2024年10月09日早盘09时40分,乐普生物-B股票出现波动,股价快速下跌5.47%。截至发稿,该股报3.800港元/股,成交量25.7万股,换手率0.02%,振幅4.98%。乐普生物-B股票所在的生物技术行业中,整体涨幅为0.41%。其相关个股中,北海康成-B、科济药业-B、绿竹生物-B涨幅较大,振幅较大的相关个股有药明巨诺-B、创胜集团-B、昭衍新药,振幅分别为14.78%、10.00%、9.55%。乐普生物-B公司简介:乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090940149719f156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090940149719f156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2473117460","title":"乐普生物-B(02157)股价上升9.653%,现价港币$4.43","url":"https://stock-news.laohu8.com/highlight/detail?id=2473117460","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473117460?lang=zh_cn&edition=full","pubTime":"2024-10-07 10:20","pubTimestamp":1728267600,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物-B(02157) 股价在上午10:20比前收市价上升9.653%,现股价为港币$4.43。至目前为止,今日最高价为$4.43,而最低价为$4.1。总成交量为46.101万股,总成交金额为港币$194.228万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410073876/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02157"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1121},{"period":"1month","weight":-0.0475},{"period":"3month","weight":0.1026},{"period":"6month","weight":-0.4016},{"period":"1year","weight":-0.1973},{"period":"ytd","weight":-0.285}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。该公司主要研发肿瘤候选药物的产品管线,包括处于临床及临床前阶段的ADC、溶瘤病毒药物及免疫疗法。该公司主要在研管线资产包括MRG003、MRG002、HX008及LP002,及三种关键临床阶段候选药物。该公司产品销往海内外市场。","exchange":"SEHK","name":"乐普生物-B","nameEN":"LEPU BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普生物-B,02157,乐普生物-B股票,乐普生物-B股票老虎,乐普生物-B股票老虎国际,乐普生物-B行情,乐普生物-B股票行情,乐普生物-B股价,乐普生物-B股市,乐普生物-B股票价格,乐普生物-B股票交易,乐普生物-B股票购买,乐普生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}